Dynamic42 is a young biotech company settled in the fast developing field of human organ-on-chip (OoC) models / microphysiological systems (MPS). Dynamic42 acts as a Contract Research Organisation (CRO) specialised in the development and marketing of human OoCs for drug screening, of associated technologies and platform solutions. Our main expertise lies in the integration of several components of the human immune system into OoC applications (immunocompetent OoC models) for drug candidate screening, host immune response studies and disease modelling. Dynamic42 aims to increase in vitro data quality and to subsequently reduce the data transferability gap between in vitro studies, animal models and clinical trials frequently leading to serious adverse effects in human patients. With our products and expertise we primarily address big pharma and academia.